CBarberMD

New clinical trial (phase 3) in metastatic colorectal cancer:

Adding tumor debulking surgery to standard palliative chemotherapy did not significantly improve survival.

Median survival:(382 pts)
• Chemo alone: 27.5 months
• Chemo + surgery: 30 months

👉 Takeaway: Surgery may not add clear survival benefit in patients with multiorgan metastases.

#MedTwitter #Oncology #ColorectalCancer https://jamanetwork.com/journals/jama/fullarticle/2846530 #press

Tumor Debulking in Combination With Chemotherapy in Multiorgan Metastatic Colorectal Cancer

This randomized clinical trial examines whether tumor debulking added to palliative chemotherapy improves survival of patients with multiorgan metastatic colorectal cancer.

Mar 16 at 6:45pmToot!